A  Study on Assessment of Quality of Life in Post Menopausal Women

 

P. Maheshwari*, B. Deepika, T. S. Shanmugarajan

Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University (VISTAS) Pallavaram, Chennai-600117, Tamilnadu, India. Email:

*Corresponding Author E-mail: mahe.mpharm@gmail.com

 

ABSTRACT:

OBJECTIVE: Menopause is defined retrospectively as the time of the final menstrual period, followed by 12 months of amenorrhea. Menopause is caused by the aging of ovaries leading to a decline in the production of ovarian gonadotropins oestrogen and progesterone.The deficiency of these hormones elicits various somatic, vasomotor, sexual, and psychological symptoms that impair the overall quality of life (QoL) of women. Hence the study was done to assess the effect of postmenopausal symptoms and their impact on women’s quality of life.

METHODOLOGY: A cross sectional study was done for the duration of six months in Employee State Insurance Corporation Hospital.  The data such as the socio-demographic information and the menstruation status and the experience of the symptoms, as were tested in the Menopause Specific Quality of Life (MENQOL) questionnaire, were collected from each patient. The women who were included in the study were divided into two groups as the early postmenopausal and the late postmenopausal groups. All statistical analyses were carried out using Graph Pad Prism 7.1.  A p-value of less than 0.05 was considered to be statistically significant.

RESULTS: A total of 200 patients met the inclusion criteria.Among the patients psychosocial symptoms were more prominent among early menopausal women when compared to late menopausal women .The vasomotor symptoms(72%),psychosocial symptoms(39.5%)physical symptoms(50.5%),sexual symptoms(26%) were prevalent and showed significance in both groups of post-menopausal women.

CONCLUSION : The age of the postmenopausal women was not proportional to any symptomatic changes to women. Among categorized symptoms of postmenopausal women in MENQOL Questionnaire, physical symptoms (low back ache, joint pain etc.,) vasomotor symptoms (eg hot flushes etc.,), psychosocial (poor memory etc.,) were prevalent and shown to have negative effect on quality life of the post-menopausal women.

 

KEYWORDS: post menopause, Quality of life, menopause, early post-menopause, late post-menopause.

 

 


INTRODUCTION:

Menopause is defined retrospectively as the time of the final menstrual period, followed by 12 months of amenorrhea.(1) It is one of the most significant events in a woman's life and brings in a number of physiological changes that affect the life of a woman permanently. The menopausal experience involves a multifaceted interaction between psychological sociocultural, and environmental factors, as well as the biological changes relating to altered ovarian hormone status or deficiency.(2, 3)

 

Menopause is caused by the aging of ovaries leading to a decline in the production of ovarian gonadotropins oestrogen and progesterone.(4) The deficiency of these hormones elicits various somatic, vasomotor, sexual, and psychological symptoms that impair the overall quality of life (QOL) of women.(5) The psychosocial, physical and vasomotor menopausal symptoms are strongly associated with QOL for both early and late menopausal women respectively.(6) It is well documented that every menopausal symptoms and socio-demographic characteristics have effect on QOL of menopausal women.(7,8) Hence the study was done to assess the effect of postmenopausal symptoms and their impact on women’s quality of life.

 

MATERIALS AND METHODS:

This research work was carried out in Employee State Insurance Corporation Hospital, Department Of General Medicine and Department of obstetrics& gynecology Aynavaram, Chennai. A crosssectional study was done for the duration of six months to assess the quality of life in postmenopausal women using MENQOL questionnaire9. Inclusion and exclusion criterion were predevised before subject recruitment, inclusion criteria Women of age between 40-70 years are included in the study. The women who were undergoing treatment for serious diseases like cancer, women who were in remission, who had history of drug or alcohol abuse and who were on hormone replacement therapy were excluded from the study. Pregnant women, lactating women were excluded. The women who were included in the study were divided into two groups, early post menopause and the late post menopause groups. The women who were above the age of 40 years and the women whose last menstrual period occurred ≥12 months were categorized as the post menopause (PM) group. The postmenopausal women who attained menopause ≤5 years were classified as the early post­menopausal group, while those who had attained menopause >5 years were classified as the late postmenopausal group. The number of patients included the study were n=200. The Chi square test and the relative risk were applied to compare the frequencies of the symptoms among the women with different menopausal statuses.All statistical analyses were carried out using Graph Pad Prism 7.1.  A p-value of less than 0.05 was considered to be statistically significant.

 

RESULTS:

Table 1-Age Based Population Distribution

S.No

Age in years

Population (n=200)

Population percentage (%)

1

40-45

43

21.40

2

46-50

52

25.80

3

51-55

30

15.20

4

56-60

40

20.20

5

61-65

35

17.40

 

TABLE 2-MENOPAUSAL STATUS

SNO

MENOPAUSAL STATUS

POPULATION

POPULATION PERCENTAGE (%)

1

EMP

        80

40.10

2

LMP

      120

59.90

 


 

TABLE 3-PREVALANCE OF POSTMENOPAUSAL SYMPTOMS IN POPULATION

SNO

SYMPTOMS

EMP

LMP

In 2 groups

Total symptoms

 

 

n=80

Mean score

n=120

Mean score

n=200

Mean score

Percentage (%)

1

Hot flushes

37

3.26

77

3.22

102

3.24

57.1%

2

Night sweats

43

2.9

54

3.17

108

2.91

54%

3

Sweating

42

2.6

45

3.01

99

2.8

49.5%

4

Dissatisfaction with personal life

33

3.4

59

3.57

84

3.48

42.0%

5

Feeling anxious or nervous

57

2.92

83

3.41

134

2.91

67.0%

6

Poor memory

51

3.07

80

3.25

127

3.12

63.5%

7

Accomplishing less than used to

43

3.07

63

3.01

102

3.13

51%

8

Feeling depressed

45

3.07

74

3.51

114

3.41

57%

9

Being impatient with other people

43

3.33

71

3.2

116

3.26

58%

10

Feeling of wanting to be alone

24

3.14

37

3.41

61

3.15

30.5%

11

Flatulence or Gas pains

24

3.20

36

2.93

61

3.04

30.5%

12

Aching in the muscles and joints

62

3.26

94

3.76

154

3.51

77.2%

13

Feeling tierd or worn out

61

3.20

87

3.33

144

3.27

72%

14

Difficulty in sleeping

39

3.51

61

3.81

100

3.65

50%

15

Aches in back of neck or head

58

3.59

86

3.53

142

3.41

71%

16

Decrease in physical strength

36

2.62

50

3.10

91

2.72

45.5%

17

Decrease in stamina

51

3.18

68

2.66

122

2.88

61%

18

Lack of energy

52

3.27

78

3.08

129

3.17

64.5%

19

Dry skin

26

2.15

35

2.5

54

2.33

27.1%

20

Weight gain

13

2.7

20

2.63

30

2.7

15%

21

Increased facial hair

28

3.11

37

2.7

63

2.86

31.5%

22

Changes in appearance, texture or tone of skin

26

2.66

34

3.10

57

2.88

28.5%

23

Feeling bloated

25

2.71

49

3.12

72

2.93

36%

24

Low back ache

61

3.69

95

3.92

158

3.80

79%

25

Frequent urination

36

3.22

51

3.68

87

3.41

43.5%

26

Involuntary urination when laughing or coughing

13

2.75

20

3.33

38

3.21

19%

27

Decrease in my sexual desire

28

1.6

74

2.10

102

1.84

51%

28

Vaginal dryness

09

.71

11

3.25

22

3.01

11%

29

Avoiding intimacy

35

1.57

81

1.66

26

2.628

13%

 

TABLE- 4-PREVALENCE OF POST MENOPAUSAL SYMPTOMS IN RELATION TO AGE IN POPULATION

Age of study population

Vasomotor symptoms

Psychosocial symptoms

Physical symptoms

Sexual symptoms

 

Present

Absent

Present

Absent

Present

Absent

Present

Absent

> 50 years

70

21

86

05

89

01

72

19

≤50years

91

18

101

08

109

01

92

17

RR

0.922

1.020

0.997

0.937

P- value

0.2838

0.7751

>0.9999

0.3598

 

TABLE- 5-PREVALENCE OF SYMPTOMS IN 2 SUB GROUPS

SNO

SYMPTOMS

EARLY MENOPAUSAL STAGE

LATE MENOPAUSAL STAGE

R Rvalue

p-value

1

Vasomotor

Present

64

16

3.429

<0.0001

Absent

28

92

2

Psychosocial

Present

75

04

22.97

<0.0001

Absent

05

116

3

Physical

Present

79

22

4.829

<0.0001

Absent

23

119

4

Sexual

Present

33

19

1.053

0.827

Absent

13

12

 

 


DISCUSSION:

The total number of patients included in the study based on their inclusion/exclusion criteria was found to be 200. The susceptibility to Post menopause was found to be common in the age range 46-50 years the mean menopausal age was found to be 51.5 years among the study population. (TABLE1). The postmenopausal status of the women were classified into two groups early post-menopausal state (EMP) 40.10% and late post-menopausal state (LMP) 59.90% (TABLE 2). Ilustrates the severity of the menopausal symptoms among the studied subjects. It can be observed that, the most severe symptoms of vasomotor, psychosocial, physical and sexual domains were, Low backache (79.1%),Aching in muscles and joints (77%), Feeling tired or worn out (72%), experiencing poor memory (63.5%), hot flushes (57.0%), and change in their sexual desire (51.1%) (TABLE 3). The psychosocial symptoms were more prominent among early menopausal women when compared to late menopausal women .The vasomotor symptoms (72%), psychosocial symptoms (39.5%) physical symptoms (50.5%), sexual symptoms (26%) were prevalent in both groups of post-menopausal women. Prevalence of post-menopausal symptoms in relation to age was calculated using Chi Square test. It was found that the age in comparison to the symptoms has not shown any significant difference (P<0.05) in the post-menopausal women, so the age was not proportional to any symptomatic changes to postmenopausal women. (TABLE 4, 5).

 

On overview of the study population results inferred that vasomotor, physical and psychosocial symptoms were more prevalent and shows significant effect in post-menopausal women.

 

CONCLUSION:

Based on this research work it can be concluded that the age of the postmenopausal women was not proportional to any symptomatic changes to women. Among categorised symptoms of postmenopausal women in MENQOL Questionnaire, physical symptoms (low back ache, joint pain etc.,) vasomotor symptoms (eg hot flushes etc.,), psychosocial (poor memory etc.,) were prevalent and shown to have negative effect on quality life of the post-menopausal women.These typesof studies can help in creating awareness and also in helping in educating women regarding an early identification of the common menopausal symptoms to improve their quality of life.

 

REFERENCES: .

1.       Soules MR, Sherman S.Executive summary. Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 76(5); 2001: 874–878

2.       Randolph JF. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopause status. J Clin Endocrinol Metab. 88(4); 2003: 1516-1522.

3.       Dennerstein L, Lehert P, Guthrie J. The effects of the menopausal transition and biopsychological factors on well-being. Arch Women Ment Health. 5(1); 2002: 15-22.

4.       Ensiyeh Jenabi, Fatemeh Shobeiri, Seyyed M.M. Hazavehei, and Ghodratollah Roshanaei. Assessment of Questionnaire Measuring Quality of Life in Menopausal Women: A Systematic Review. 30(3); 2015: 151-156.

5.       Deeks AA, McCabe MP. Well-being and menopause: an investigation of purpose in life, self-acceptance and social role in premenopausal, perimenopausal and postmenopausal women. Qual Life Res. 13(2); 2004:389-398.

6.       Peeyananjarassri K, Menopausal symptoms in a hospital-based sample of women in southern Thailand. Climacteric. 9(1); 2006: 23-29.

7.       Dhillon HK, Singh HJ. Prevalence of menopausal symptoms in women in Kelantan, Malaysia. Maturitas. 54(3); 2006: 213–221.

8.       RachelE.Williams. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health –related quality of life. Maturitas. 62(2); 2009; 153-159.

 

 

 

 

Received on 16.08.2016          Modified on 12.09.2016

Accepted on 20.10.2016        © RJPT All right reserved

Research J. Pharm. and Tech. 2017; 10(1): 15-17.

DOI: 10.5958/0974-360X.2017.00004.X